Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SNPS vs MRNA✓SelectedUSD · MRNASNPS vs MRNA performance historyLatest closeAs of-3.05%11/16
Stock and ETF performance explorer

SNPS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+402.5%
MRNA return
+878.5%
Excess return
-476.0%
Maximum drawdown
-43.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.0%-3.6%+0.6%-2.9%
7D-5.5%-20.0%+14.5%-4.4%
30D-2.9%-1.3%-1.7%-2.9%
3M+4.7%+240.0%-235.3%-6.7%
6M-12.2%+339.0%-351.1%-24.2%
YTD-6.0%+630.0%-636.0%-23.5%
1Y+13.2%+769.1%-755.9%-9.6%
3Y-17.3%+181.2%-198.5%-29.1%
5Y+24.9%-8.1%+33.0%+13.3%
All+402.5%+878.5%-476.0%+309.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling